ghk-cu immunogenicity low injectable ghk cu clinical trial gene modulation typical dosage for injection GHK-Cu Peptide Therapy: The Definitive Guide to GHK-Cu FDA adds non-injectable GHK-Cu back

Improves joint mobility and comfort

Town Center

GHK-Cu has been associated with endothelial recruitment and neovascular support in wound models

10.2174/1381612824666180712110447 101 SeiwerthS.SikiricP.GrabarevicZ.ZoricicI.HanzevackiM.LjubanovicD.et al (1997)

Pernicious anemia is a lifelong condition requiring ongoing B12 injections (typically monthly after the initial loading doses)

Unless otherwise prescribed by your doctor, the usual dose is: At the start of treatment, 1 ml (1 ampoule) is administered once or twice a week for the first two weeks after diagnosis, corresponding to 1000-2000 g of cyanocobalamin per week